Ep. 992 - Trump’s Big Reopening Plan

Episode Summary

Executive Summary: The episode argues that COVID-19 policy should be driven by age and health risk, not blanket lockdowns. Shapiro cites death and antibody data to say young, healthy people face far lower fatality risk than older and vulnerable groups, supports reopening with targeted precautions, and highlights promising treatments, while criticizing media, Democrats, and Pelosi for delaying small-business aid.

Main Topics: COVID-19 risk is highly stratified by age and health (Priority: 5/5): Shapiro emphasizes that the virus is far more dangerous to older adults and people with pre-existing conditions, and that public policy should reflect those differences rather than treating all groups as equally vulnerable. Interpreting deaths and fatality statistics correctly (Priority: 5/5): He warns against misleading cumulative charts and argues that daily trends, age breakdowns, and non-COVID mortality context are essential to understanding the real trajectory of the pandemic. Antibody testing suggests far more infections than confirmed cases (Priority: 5/5): The episode uses New York and Netherlands antibody evidence to argue the infection denominator is much larger than official case counts imply, lowering the apparent case fatality rate. Reopening should be phased and state-led (Priority: 4/5): Shapiro supports reopening, especially for low-risk populations, and reviews the White House phased plan while arguing its criteria may be too restrictive and difficult to satisfy in practice. Promising treatments may reduce the urgency of lockdowns (Priority: 4/5): He discusses prone positioning in ICUs and early encouraging reports on remdesivir, suggesting that effective treatment could materially reduce death risk even before a vaccine is available. Economic damage and small-business aid (Priority: 5/5): The episode criticizes Democrats, especially Nancy Pelosi, for delaying replenishment of small-business loan funds while many firms are shut down and unemployment is surging. Media and identity-politics framing (Priority: 3/5): Shapiro accuses the media and Democrats of overstating uniform risk and of steering the debate toward racial narratives rather than core factors like age, poverty, and pre-existing conditions.

Key Arguments: COVID-19 risk is not uniform; age and underlying conditions are the dominant factors determining outcomes, so reopening policy must tranche the population accordingly. Daily death counts and age-specific mortality matter more than cumulative charts, which can exaggerate the appearance of relentless growth. Antibody studies imply many more people have already had COVID-19 than diagnosed case counts suggest, meaning the infection fatality rate is likely much lower than initially claimed. Young, healthy people face very low mortality risk, so a rational reopening should allow them to return to work with precautions while protecting seniors and medically vulnerable people. Temperature checks are of limited value because people can be infectious before symptoms appear. A vaccine may be delayed or only partially effective if the virus mutates; therefore treatment advances are crucial. The U.S. should prioritize economic reopening because the shutdown is causing massive unemployment and business failures. Congress should immediately replenish small-business aid because the government imposed the shutdown and therefore should compensate affected businesses.

Data Points: U.S. recorded deaths in a single day: over 4,500 - Reported as a very bad day for COVID-19 fatalities in the United States U.S. weekly COVID-19 deaths: about 12,400 from April 6 to April 12 - Used to compare COVID-19 with heart disease and cancer mortality Typical weekly deaths from cancer: about 11,000 per week - Comparison benchmark for U.S. mortality Typical weekly deaths from heart disease: about 13,000 per week - Comparison benchmark for U.S. mortality Deaths age 15-24 in the U.S.: 13 COVID-19 deaths - CDC age breakdown from Feb. 1 to Apr. 11 Total deaths age 15-24 in the U.S.: over 5,000 - Used to show COVID-19 is a small share of deaths in this age group Deaths age 25-34 in the U.S.: 113 COVID-19 deaths out of 11,000 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 Deaths age 35-44 in the U.S.: 289 COVID-19 deaths out of nearly 16,000 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 Deaths age 45-54 in the U.S.: 751 COVID-19 deaths out of 30,500 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 Deaths age 55-64 in the U.S.: 1,773 COVID-19 deaths out of 74,000 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 Deaths age 65-74 in the U.S.: 2,900 COVID-19 deaths out of 114,000 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 Deaths age 75-84 in the U.S.: 3,576 COVID-19 deaths out of 144,000 total deaths - CDC age breakdown from Feb. 1 to Apr. 11 New York City under-45 deaths with no underlying conditions: 29 - Probable COVID-19 deaths in NYC, PDF last updated Apr. 15 New York City under-65 deaths with no underlying conditions: 96 - Calculated from the transcript as 29 + 7 + 67 Netherlands antibody prevalence: 3% of the population - Announced by the head of the Netherlands National Institute for Health Netherlands diagnosed cases: 28,383 diagnosed cases - Used to contrast confirmed cases with estimated infections Netherlands deaths: 3,327 deaths - Used to illustrate the difference between reported and inferred fatality rates Netherlands estimated infections from antibody data: about 518,400 cases - Derived from 3% of roughly 18 million residents PPP funding initial allocation: $349 billion - Original small-business aid amount that ran out quickly PPP loans approved: more than 1.4 million - Approved as of Wednesday evening before funds were exhausted U.S. unemployment claims: 22 million in four weeks - Presented as the fastest spike in American history Singapore new daily high: 728 cases - Cited as evidence of a second wave after reopening Prone positioning effectiveness: "100%" - Doctor quoted saying the simple ICU maneuver is saving lives University of Chicago remdesivir trial size: 125 people - Patients enrolled in Gilead Phase III trials University of Chicago severe cases in remdesivir trial: 113 severe cases - Subset of the 125 trial participants

Pivotal Quotes: "If you are young and you are healthy, your chances of dying from this thing are near zero." — Ben Shapiro: Argument for age-based reopening policy and against blanket shutdowns "We’re saving lives with this 100%." — Dr. Mangala Narasimhan: Discussion of prone positioning for severely ill COVID-19 patients "The government is driving a railroad right through your business right now. They need to compensate you for that." — Ben Shapiro: Defense of small-business relief as compensation for government-imposed shutdowns

Implications: The episode pushes for reopening economies sooner, with focused protection for the elderly and vulnerable, aggressive testing and treatment development, and immediate small-business relief. It predicts prolonged political conflict over lockdowns and aid.